Effects of luseogliflozin, a sodium-glucose co-transporter 2 inhibitor, on 24-h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, crossov (Q41154151)
Jump to navigation
Jump to search
scientific article published on 30 April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of luseogliflozin, a sodium-glucose co-transporter 2 inhibitor, on 24-h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, crossov |
scientific article published on 30 April 2015 |
Statements
1 reference
Effects of luseogliflozin, a sodium-glucose co-transporter 2 inhibitor, on 24-h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, crossov (English)
1 reference
R Nishimura
1 reference
T Osonoi
1 reference
S Kanada
1 reference
H Jinnouchi
1 reference
K Sugio
1 reference
H Omiya
1 reference
M Ubukata
1 reference
S Sakai
1 reference
Y Samukawa
1 reference
1 reference
1 reference
Identifiers
1 reference